Tradestie Institutional Equity Comparison Engine

ATYR vs SRZN โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-17 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ATYR Overall Edge

ATYR Captures Institutional Edge (2โ€“1 Pillars ยท 2โ€“5 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to aTyr Pharma, Inc. Common Stock (ATYR) driven by superior Momentum & Technical, Options & Structure while SRZN counters with relative strength in Growth & Margin. Fundamentally, ATYR trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus SRZN at N/M Forward P/E and -485.4% operating margin (+408.6% YoY). In options structure, ATYR sits in UNCLASSIFIED (36th %ile IV; Dealer Gamma Walls on Pro) against SRZN sits in CONSOLIDATION (5th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
ATYR N/M vs SRZN N/M Fwd P/E
Growth & Margin Winner SRZN
Op Margin 0.0% vs -485.4% ยท YoY +0.0% vs +408.6%
Momentum & Technical Winner ATYR
1Y +558.7% vs +132.4% ยท 52W Pos 62% vs 70%
Options & Structure Winner ATYR
UNCLASSIFIED (36th %ile IV) vs CONSOLIDATION (5th %ile IV)
ATYR NASDAQ
aTyr Pharma, Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$4.96
-5.34% 1D
Market Cap $15.6M
1M Return +2788.76%
1Y Return +558.7%
Forward P/E N/M
Unified AI Score
34.3 / 100 SELL
Tech 50.0 Fund 36.0 Flow 69.0 Mom 50.0
SRZN NASDAQ
Surrozen, Inc. Common
Biological Products, (No Disgnostic Substances)
$30.16
-6.68% 1D
Market Cap $602.5M
1M Return +26.51%
1Y Return +132.36%
Forward P/E N/M
Unified AI Score
33.2 / 100 SELL
Tech 50.0 Fund 34.0 Flow 65.0 Mom 40.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: ATYR +558.7% SRZN +132.36% Spread: +426.34 pp (ATYR Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period ATYR Revenue SRZN Revenue ATYR Op. Margin SRZN Op. Margin Margin Edge
FY2019 $0M N/A -5445.0% N/A ATYR
FY2020 $10M N/A -152.2% N/A ATYR
FY2022 $10M $10M -446.8% -354.7% SRZN
FY2023 $0M N/A -15557.8% N/A ATYR
FY2024 $0M $10M -28899.6% -239.7% SRZN
FY2025 $0M $0M -40856.3% -1210.6% SRZN

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: ATYR (2) vs SRZN (5)
Institutional Metric ATYR SRZN Criterion Row Winner
Market Capitalization Scale $15.6M $602.5M Larger Scale SRZN
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +0.0% +408.6% Higher Growth SRZN
Operating Margin (TTM) Profitability 0.0% -485.4% Higher Margin ATYR
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -93.7% -62.8% Higher ROE SRZN
52-Week Range Position Momentum 62% ($0โ€“$8) 70% ($12โ€“$38) Stronger Trend SRZN
Beta / 30D Volatility Risk Regime -9.67ฮฒ ยท 13806% Vol 1.28ฮฒ ยท 70% Vol Lower Realized Risk SRZN
Unified Institutional Score Composite Signal 34.3 / 100 (SELL) 33.2 / 100 (SELL) Higher Composite ATYR

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full ATYR vs SRZN Buy Guide
ATYR UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 36th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live ATYR Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
SRZN CONSOLIDATION
38d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 5th %ile
IV Regime Compressed (<25th %ile)
Live SRZN Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither ATYR nor SRZN registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.